• Human JAM3 (Junctional Adhesion Molecule 3) Sandwich ELISA Kit Ready-To-Use (STJE0016507)

Human JAM3 (Junctional Adhesion Molecule 3) Sandwich ELISA Kit Ready-To-Use (STJE0016507)

SKU:
STJE0016507

Shipping:
Free Shipping
Current Stock:
Applications: ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Sensitivity: 6.2pg/mL
Detection Limit: 15.6-1000pg/mL
Short Description: This JAM3 Sandwich ELISA Kit, Ready-To-Use is an in-vitro enzyme-linked immunosorbent assay for the measurement of samples in human cell culture supernatant, serum and plasma (EDTA, citrate, heparin).
Storage Instruction: The whole kit may be stored at-20°C for up to 12 months from receipt. An unopened kit may be stored in the fridge at 2-8°C for up to 6 months. Once opened store individual kit contents according to components table provided with the kit.
Assay Time: 3 hrs
Gene Symbol: JAM3
Gene ID: 83700
Uniprot ID: JAM3_HUMAN
Immunogen Region: Ready-To-Use
Sample Type: serum, plasma or other biological fluids.
Tissue Specificity Detected on round and elongated spermatids (at protein level). Highest expression in placenta, brain and kidney. Significant expression is detected on platelets. Expressed in intestinal mucosa cells. Expressed in the vascular endothelium. Found in serum (at protein level). Also detected in the synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis or ostearthritis (at protein level).
Post Translational Modifications Proteolytically cleaved from endothelial cells surface into a soluble form by ADAM10 and ADAM17.the release of soluble JAM3 is increased by pro-inflammatory factors. S-palmitoylated by ZDHHC7. S-palmitoylation promotes expression at tight junctions.
Function Junctional adhesion protein that mediates heterotypic cell-cell interactions with its cognate receptor JAM2 to regulate different cellular processes. Plays a role in homing and mobilization of hematopoietic stem and progenitor cells within the bone marrow. At the surface of bone marrow stromal cells, it contributes to the retention of the hematopoietic stem and progenitor cells expressing JAM3. Plays a central role in leukocytes extravasation by facilitating transmigration through the endothelium. Plays a role in spermatogenesis where JAM2 and JAM3, which are respectively expressed by Sertoli and germ cells, mediate an interaction between both cell types and play an essential role in the anchorage of germ cells onto Sertoli cells and the assembly of cell polarity complexes during spermatid differentiation. Also functions as a counter-receptor for ITGAM, mediating leukocyte-platelet interactions and is involved in the regulation of transepithelial migration of polymorphonuclear neutrophils (PMN). Plays a role in angiogenesis. Plays a role in the regulation of cell migration (Probable). During myogenesis, it is involved in myocyte fusion. Soluble form of JAM-C: Promotes chemotaxis of vascular endothelial cells and stimulates angiogenesis.
Protein Name Junctional Adhesion Molecule C
Jam-C
Jam-2
Junctional Adhesion Molecule 3
Jam-3 Cleaved Into - Soluble Form Of Jam-C
Sjam-C
Database Links Reactome: R-HSA-202733
Reactome: R-HSA-216083
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Cell Junction
Desmosome
Tight Junction
Detected In The Acrosome Region In Developing Spermatids
In Epithelial Cells
It Is Expressed At Desmosomes But Not At Tight Junctions
Localizes At The Cell Surface Of Endothelial Cells
Treatment Of Endothelial Cells With Vascular Endothelial Growth Factor Stimulates Recruitment Of Jam3 To Cell-Cell Contacts
Soluble Form Of Jam-C: Secreted
Alternative ELISA Names Junctional Adhesion Molecule C ELISA kit
Jam-C ELISA kit
Jam-2 ELISA kit
Junctional Adhesion Molecule 3 ELISA kit
Jam-3 Cleaved Into - Soluble Form Of Jam-C ELISA kit
Sjam-C ELISA kit
JAM3 ELISA kit
UNQ859 ELISA kit
PRO1868 ELISA kit
output

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance